Page 1

FINANCIAL INFORMATION INDI INDE Quarterly Consolidated Sales ( in € M ) lisi The LISI Group confirms its growth momentum , driven by the aerospace sector , with strong growth in the 3rd quarter of 2026 : + 12.8 % and compared to the first nine months of 2025 , + 8.0 % LISI : consolidated revenue on a like - for - like basis and at constant exchange rates continues to post double - digit growth : + 10.3 % , accelerating in the 3rd quarter to + 12.1 % , ■ LISI AEROSPACE : revenue of 1,009.4 € M , continuing to accelerate to + 22.5 % in the 3rd quarter and + 14.3 % for the first nine months of 2026 , ■ LISI AUTOMOTIVE : revenue down 5.2 % over the first nine months of the fiscal year ( down 7.4 % in the 3rd quarter ) , amid a challenging global production environment for the division's major customers . 468 475 473 In ЄM 450 442 437 420 Changes 2026 2025 * 2026 / 2025 2026/2025 on a like - for - like basis¹ Q1 468,0 442,0 + 5,9 % + 10,9 % 282 Q2 474,9 449,7 + 5,6 % + 7,0 % Q3 473,2 419,5 +12,8 % + 12,1 % 3rd Quarter ended 1 416,0 1 311,22 + 8,0 % + 10,3 % September 30 , T1 T2 2026 T3 T4 2025 EBIT * and Net profit in ЄM 98,7 90,7 37,5 56,0 2023 2024 ** EBIT ⚫ After participation and profit - sharing expenses Net profit ** Figures restated for the sale of LISI MEDICAL in October 2025 161,0 139,7 2025 ** Consolidated revenue for the first nine months of the year totaled 1,416.0 € M , up 8.0 % compared with the same period in 2025 , and reflects the following factors : • • • an average negative currency impact of -24.8 € M ( 1.8 % of revenue ) , resulting primarily from the weakening of the average U.S. dollar exchange rate against the euro ; a scope - of - consolidation effect of +4.7 € M ( 0.3 % of revenue ) related to the acquisition of LISI AUTOMOTIVE Hungary on September 30 , 2025 ; a scope - of - consolidation effect of -8.0 € M ( 0.6 % of revenue ) related to the removal of Ankit ( India ) from the LISI AEROSPACE scope of consolidation on December 31 , 2025 . For the 3rd quarter , revenue rose sharply by 12.8 % compared to the same period last year . On a year - to - date basis and adjusted for currency and scope changes , organic growth remained at a high level of + 10.3 % of revenue . 1 The change at constant scope and exchange rates is calculated as follows : By converting the revenue of companies whose financial statements are denominated in foreign currencies at the average exchange rate for year N - 1 or month M - 1 By converting revenue invoiced in currencies other than the local currency at the average exchange rate for year N - 1 or month M - 1 By restating additions to or disposals from the scope of consolidation to establish a comparable basis . 2 The consolidated figures for 2025 do not include LISI MEDICAL's revenue for the first quarter of 2025 , which amounted to 44.7 € M , 42.4 € M for the second quarter , and 44.9 ЄM for the third quarter . TRADING AGREEMENT : ODDO BHF CORPORATE - +33 ( 0 ) 1 44 51 86 80